Hidehiro Iwakawa, MD, PhD retweeted
🔥 Beyond placebo!
Does AF ablation really improve quality of life?
Our meta-analysis of sham-controlled RCTs shows that with AF ablation:
✅ +13.5 AFEQT points
✅ 51% lower AF recurrence
✅ Benefit beyond active-treatment controls
....and this is with SHORT follow-up and an "active treatment" control!
📖 Kakarla et al. Heart Rhythm, 2026. bit.ly/4iDdvnL
@Dr_Saikiran_K @Hidehiro_1986 @DrJasonAndrade @JonathanAriya @Mel_Gunawardene @nmarrouche @melissaemm1 @Elliott_AD @peterkistler3
#AtrialFibrillation #EP
#CHRD @HRSonline @thecsanz @hrs_journal
🤖 Made with AI
Hidehiro Iwakawa, MD, PhD retweeted
Congratulations to Dr. Hidehiro Iwakawa, Dr. Prashanthan Sanders, and the full author team on their new publication in Heart Rhythm: "Leadless pacemaker, right ventricular pacing burden, and heart failure."
It's a privilege to see PaceMate data support research that shapes how clinicians care for device patients.
Read the full open-access study: lnkd.in/esy7mjb9
Hidehiro Iwakawa, MD, PhD retweeted
モンベルすごいな!ちょっと感動
webshop.montbell.jp/sp/goods…
Day 3 startted with great conversation between @PrashSanders and Prof. Michel Haïssaguerre‼️
#HRX2026
Hidehiro Iwakawa, MD, PhD retweeted
Engaging discussion on social robotics and the future of health education @HRX2026
Hidehiro Iwakawa, MD, PhD retweeted
First day at #HRX for the Innovation Summit and the technology pipeline is insane 🚀. What a time to be an EP fellow! #HRX #EP #MedTech
@PrashSanders @experienceHRX
Such exciting presentations at #HRX2026 in Atlanta!!
Pleased to share our new paper!
The findings highlight that RV pacing burden was associated with a proportional increase ↗️ in HF risk in leadless pacemaker.
#CHRD @UniofAdelaide @PrashSanders
Leadless Pacemaker, Right Ventricular Pacing Burden, and Heart Failure #OpenAccess
@Hidehiro_1986 @PrashSanders
heartrhythmjournal.com/artic…
Hidehiro Iwakawa, MD, PhD retweeted
心電図検定対策講習会 in 秋田のご案内
日時:2026年10月25日(日)
会場:市立秋田総合病院 5階講堂
午前:3級、4級トレーニングコース
午後:1級、2級トレーニングコース
A:3~4級コース 残席数に余裕あり
B:2~1級コース 残席わずか
C:AB通しコース 残席わずか
new.jhrs.or.jp/seminar/kente…
Happy to have the opportunity to present two abstracts at #ESCCongress 2026!!
Hidehiro Iwakawa, MD, PhD retweeted
Do you belong at HRX Live?
Dr. Prashanthan Sanders (@PrashSanders) addresses this question directly in this week's Inside HRS interview with HRX Live 2026 Executive Producer Dr. Jonathan Piccini (@JonPicciniSr) and HRS President Dr. Sana Al-Khatib (@SanaAlkhatib9).
HRX began with a reputation for innovation, but today it's about something bigger. It's about bringing together the people closest to the everyday challenges in cardiovascular care and creating the conversations that lead to better solutions in the next five to ten years.
Whether you're caring for patients, conducting research, developing technology, launching new ideas, or leading change in your organization, your voice belongs in the room.
▶️ With only 7 weeks until HRX Live 2026 begins, make a plan to join us in Atlanta and be part of the conversations: experiencehrx.com/hrx-live/?…
HRX Live 2026 | September 18-20, 2026 | Signia by Hilton Atlanta
An @HRSonline Experience
HRX Live 2026 Production Team: @JonPicciniSr @PrashSanders @TinaBaykaner45 @brynndechert30 @MehakDhande @DavidDuncker @J_Hendriks1 @jasoncjacobson @RCKowalMD @Dominik_Linz Mike Lloyd, Olivier Manfredi, @drsuneet @Drdevignair
@jenniferavari @ba_steinberg @EmmaSvennberg @KTamirisaMD @NTrayanova @leftbundle
#Xplorers2026 #HRXLive #HRX2026 #Electrophysiology #CardiologyInnovation #MedTech #DigitalHealth #AIinHealthcare #EPeeps
Hidehiro Iwakawa, MD, PhD retweeted
In swine, PFA near the sinus node and His bundle caused distance-dependent conduction injury #Epeeps @iwanari65284818 @TAMA07120380
ahajrnls.org/4vOGRmG
A new paper published💡
We investigated the efficacy of Spot ROI, an X-ray filtering function, during AF ablation.🫀
Congratulations Nobuhiro Suzuki @76qzd2! 👏
Spot ROI, a novel X-ray filter, effectively reduced patient and operator radiation exposure during AF ablation without compromising procedural success or complication rates.
By Nobuhiro Suzuki @76qzd2
doi.org/10.1253/circrep.CR-2…
#circ_rep #CardioX
Hidehiro Iwakawa, MD, PhD retweeted
新しい透視フィルター機能であるSpot ROIは心房細動カテーテルアブレーションにおいて手技成功率や手技時間を損なうことなく患者および術者の放射線被曝を低減した
By 鈴木 暢容 @76qzd2
doi.org/10.1253/circrep.CR-2…
#circ_rep #CardioX
Hidehiro Iwakawa, MD, PhD retweeted
Right Ventricular Dysfunction in Patients with Symptomatic Atrial Fibrillation: Prevalence and Functional Implications #OpenAccess
@JenelleDziano @Elliott_AD
heartrhythmjournal.com/artic…
Hidehiro Iwakawa, MD, PhD retweeted
What an amazing educational collaboration it was - well done @HRSonline and @thecsanz
A huge thank you to all involved in delivering the Advances in Pacing and Conduction System Pacing (PCSP) Summit in Melbourne over two amazing days. @HRSonline @PrashSanders
#PCSP2026 #CSANZ #HRS #Cardiology #Electrophysiology #ConductionSystemPacing
Hidehiro Iwakawa, MD, PhD retweeted
Showcase of some work from Adelaide and the #CHRD Group to start the second day of this amazing CSP summit 🎓
🐑 Sanjai PV presenting on an ex-vivo ovine model to evaluate CSP in hypertrophied septae
🔋@JenishShroff displaying the results of the PACE-HF trial
@thecsanz
Hidehiro Iwakawa, MD, PhD retweeted
Aldo Rinaldi walking us through Wise CRT at the inaugural @HRSonline and @thecsanz summit









































